ARTICLE | Company News
ExperGen, Thallion cancer news
July 13, 2009 7:00 AM UTC
Thallion said a binding arbitration proceeding has been started related to a dispute with ExperGen over TLN-232 (CAP-232), which Thallion (formerly Caprion Pharmaceuticals Inc.) licensed from ExperGe...